跳至主要内容
临床试验/CTRI/2018/06/014573
CTRI/2018/06/014573已完成未知

A comparative evaluation of safety and efficacy of formoterol with tiotropium bromide and formoterol with glycopyrronium in patients of COPD

Department of pharmacology0 个研究点目标入组 160 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • patients with grade II and III COPD in age group of 18 - 65 of both genders will be enrolled in the study

排除标准

  • Complicated cases of COPD patients
  • Patients with clinically significant lung disease other than COPD
  • Patients with respiratory failure
  • Patients who are on systemic corticosteroid therapy
  • Pregnant and Lactating patients.
  • Psychotic patients.
  • Critically ill patients.
  • Patients with comorbid conditions like myocardial infarction, diabetes mellitus 5
  • Known cases of HIV/HBsAg /Anti-HCV and immuno-compromised patients.

研究者

相似试验